title: The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy.
authors.affiliation: Dallas Veterans Affairs Medical Center, TX, USA.
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Dowell
authors.forename: John D
authors.initials: JD
authors.lastname: Minna
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D066246:ErbB Receptors / Q000235:genetics* / Q000378:metabolism; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation / Q000187:drug effects*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib